1-3 of 3
Johannes Spehr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic CAR-T therapy AVC-201 in AML positive for CD123

Free
Martin Wermke, Joerg Westermann, Stephan Metzelder, Elisa Sala, Veit Buecklein, Marion Subklewe, Mojca Jongen-Lavrencic, Sabrina Kraus, Felicitas R Thol, Adela Neagoie, Jingting Luan, Jonas A Schäfer, Arjan van de Loosdrecht, Remco Molenaar, Manfred Klevesath, Marc Cartellieri, Reynald Lescarbeau, Johannes Spehr, Andrew Schiermeier, Matti Vänskä
Journal: Blood
Blood (2025) 146 (Supplement 1): 3426.
https://doi.org/10.1182/blood-2025-3426
Published: 2025
Journal Articles

Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies

Free
Johannes Spehr, Jan-Erik Meyer, Simon Loff, Anika Langer, Moritz Langer, Ben Boyerinas, Isabelle Le Mercier, Reynald Lescarbeau, Marc Cartellieri, Armin Ehninger
Journal: Blood
Blood (2023) 142 (Supplement 1): 2059.
https://doi.org/10.1182/blood-2023-180873
Published: 2023
Journal Articles

Late-Stage Preclinical Characterization of Switchable CD123-Specific CAR-T for Treatment of Acute Leukemia

Free
Simon Loff, MSc, Jan-Erik Meyer, Dipl. Biol., Josephine Dietrich, Msc, Johannes Spehr, PhD, Riewaldt Julia, PhD, Malte von Bonin, MD, Cordula Gründer, PhD, Kristin Franke, PhD, Anja Feldmann, PhD, Michael Bachmann, MD, Gerhard Ehninger, MD, Armin Ehninger, PhD, Marc Cartellieri, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 964.
https://doi.org/10.1182/blood-2018-99-113288
Published: 2018